NanoVation Therapeutics (NTx) is an early-stage gene therapy company developing next-generation platform technologies utilizing lipid nanoparticles for the safe and efficient delivery of nucleic acids to a variety of tissues. Focused on translating personalized gene therapies to the clinic, NTx aims to treat and prevent multiple age-related diseases enabling a healthier tomorrow, TODAY.